Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02979327
Other study ID # 16-004743
Secondary ID
Status Completed
Phase Early Phase 1
First received
Last updated
Start date June 1, 2018
Est. completion date July 23, 2021

Study information

Verified date April 2022
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is designed to investigate the cardiovascular response (blood pressure, heart rate, electrocardiographic response and blood vessel reactivity response) to taking Adderall in healthy adults.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date July 23, 2021
Est. primary completion date July 23, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Adults 18 years of age and older 2. Healthy subjects without known cardiovascular disease, thyroid disease or documented mental health illness 3. Subjects who are on no medications 4. Subjects with no prior history of regular amphetamine use, and non-prescription stimulants 5. Nonsmokers Exclusion Criteria 1. Subjects with known cardiovascular disease, thyroid disease 2. Subjects with history of psychotic disorders/mental health illness, including but not limited to anxiety, depression, bipolar disorder; history of substance abuse or dependence 3. Subjects currently taking medications 4. Prior history of regular amphetamine use, or non-prescription stimulants 5. Smokers 6. Pregnant subjects 7. Known lactose intolerance (due to presence of lactose in the prepared medication) 8. Family history of sudden cardiac death

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Adderall capsule
Amphetamine
Placebo capsule
Placebo capsule

Locations

Country Name City State
United States Mayo Clinic in Rochester Rochester Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in blood pressure Baseline; 3 hours after intake of active drug/placebo drug
Primary Change in heart rate Baseline; 3 hours after intake of active drug/placebo drug
Secondary Change in plasma catecholamines Baseline; 3 hours after intake of active drug/placebo drug
See also
  Status Clinical Trial Phase
Completed NCT04585568 - Validation of Ballistocardiographic Biosensors and Other Hemodynamic Measures for Healthy Subjects
Not yet recruiting NCT02202239 - Effect of Induction and Maintenance of Anesthesia With Etomidate on Hemodynamics and Oxidative Stress in Diabetic Patients Phase 4
Terminated NCT01116973 - Reliability of Central Venous Pressure Measurements N/A
Recruiting NCT05752409 - Comparison of Esketamine-Propofol and Fentanyl-Propofol N/A
Completed NCT04595591 - Observation of Propofol Titration at Different Speeds N/A
Not yet recruiting NCT03729817 - REstoring Flow by REvascularization With Submaximal Angioplasty in Hemodynamic IntraCranial Atherosclerotic Stenosis N/A
Completed NCT01974557 - The Effect of Age on the Hemodynamic Response During Rest and Exercise in Healthy Humans N/A
Completed NCT00620386 - Endotracheal Intubation Using Bonfils Fibrescope Without Neuromuscular Blockade Phase 2/Phase 3
Recruiting NCT06082856 - Evaluation of the Hemodynamic Effect of Dexmedetomidine in Scheduled Outpatient Surgery N/A
Recruiting NCT04665817 - Diagnostic Accuracy of CCTA-derived Versus AngiogRaphy-dErived QuantitativE Flow Ratio (CAREER) Study
Recruiting NCT03684291 - Hemodynamic Effects of Ventilation Modes
Recruiting NCT04291196 - Virtual Reality to Reduce Pre-procedure Anxiety Prior ECT N/A
Terminated NCT02495662 - The LIPMAT Study: Liposomal Prednisolone to Improve Hemodialysis Fistula Maturation Phase 2
Completed NCT01559285 - Effects of Epidurally Administered Ropivacaine Concentration on the Hemodynamic Parameters Phase 4
Completed NCT04131699 - Electrical Velocimetry (ICON Cardiometry ) Assessment of Hemodynamic Changes During Pediatric Thoracoscopic Surgery
Completed NCT05145114 - Hemodynamic Repercussions in Different Therapeutic Positions in Premature Newborn N/A
Completed NCT04419662 - Evaluation of Patients After Cardiac Surgery: Novel Ultrasound Parameters for Quantification of Renal Perfusion & Analysis of Phenylephrines' Effect on Invasive Haemodynamics and Echocardiographic Measures Phase 4
Completed NCT02902068 - Hemodynamic Monitoring in Women Throughout Cesarean Sections
Recruiting NCT00730899 - Association Study of Gene Polymorphisms With Cardiac Performance N/A
Recruiting NCT03855579 - Levosimendan Versus Milrinone in Off Pump CABG Surgery Phase 4

External Links